Amphastar Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Amphastar Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amphastar Pharmaceuticals Inc Strategy Report
- Understand Amphastar Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on Amphastar Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
09 Nov 2021 | Amphastar Pharma Files Registration Statement to Raise Up to USD250 Million in Public Offering of Securities | Equity Offering | - |
Amphastar Pharmaceuticals Inc |
06 May 2021 | Amphastar Pharmaceuticals to Acquire 18% Additional Stake in Amphastar Nanjing Pharmaceuticals | Acquisition |
Amphastar Pharmaceuticals Inc
|
Amphastar Nanjing Pharmaceuticals Co Ltd
|
09 Nov 2018 | Amphastar Pharmaceuticals Files Registration Statement for USD250 Million in Public Offering | Equity Offering | - |
Amphastar Pharmaceuticals Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer